This review looked at the role of macrophages, which are a type of immune cell. These cells have a unique ability called plasticity. This means they can change their behavior based on signals from their environment. They can switch between two main types: M1, which causes inflammation, and M2, which helps with repair and healing.
Researchers found that these different cell types play important roles in how the body reacts to organ transplants. Specifically, the study looked at how macrophage behavior relates to issues like acute rejection, chronic rejection, graft repair, and fibrosis. By understanding these shifts, scientists hope to find ways to control inflammation more precisely.
Because this is a systematic review of biological processes rather than a clinical trial on patients, it does not provide specific medical treatments or protocols. It shows that targeting these cell types could be a way to manage transplant-related problems in the future. Patients should talk to their doctors about current treatment options for transplant care.
